Julie

Votre espace se prépare…

Preparing your space…

Le chargement prend plus de temps que prévu.
Réessayer
Loading is taking longer than expected.
Try again
Skip to main content

Records · procedure · next step

Medicinal SPC: patent and authorisation dossier

A medicinal SPC dossier connects the identified product with a basic patent, valid marketing authorisation and the relevant first-authorisation record. France uses the EU certificate framework; Switzerland has its own statutory conditions and filing triggers. Preserve the patent holder’s entitlement and the actual dated acts. This preparation does not establish eligibility, calculate an individual filing deadline or turn marketing permission into supplementary patent protection.

General information and document preparation. The facts, actual procedural acts and applicable versions must be checked.

Julie’s legal research currently covers French law. The Swiss sections prepare documents; they do not establish Swiss-law product capability.

Julie by AlphaDeep

Illustrative conversation
Example question

France: which product and patent records are connected?

Julie Illustration

Match the identified product, in-force basic patent and valid authorisation. Article 3 also addresses the first authorisation and earlier certificate condition in the relevant member state.

Read the references

Which patent and authorisation are involved? Julie’s legal research currently concerns French law.

Law:
France / Switzerland

3 free questions at signup. Avoid names and sensitive information.

France: which product and patent records are connected?

Match the identified product, in-force basic patent and valid authorisation. Article 3 also addresses the first authorisation and earlier certificate condition in the relevant member state.

France: who holds the certificate entitlement?

Article 6 assigns it to the basic-patent holder or successor. Preserve the actual title chain rather than assuming the marketing-authorisation holder is the applicant.

Prepare the records

Julie’s legal research currently covers French law. The Swiss sections prepare documents; they do not establish Swiss-law product capability.

Use masked references. Nothing is sent before your explicit continuation.

Synthetic example

Product, patent, authorisation and SPC application matrix

Medicinal product
Synthetic P1; exact product to document
Basic patent
B1; in-force status to establish
Holder and entitlement
T1; transfer instrument absent
Authorisations
A1; actual copy to match
Act chronology
Stated authorisation2026-10-01; grant date to verify
Earlier certificates
Search and scope undocumented
Application and fee
C1being prepared; no filing established

This record organises supplied documents and values; it certifies no entitlement, permission or safety.

France: why keep authorisation and patent-grant dates?

Article 7 distinguishes a six-month authorisation trigger and a later patent-grant trigger. Neither date should be substituted for the other without establishing the branch.

France: does an initial request include an automatic paediatric extension?

No. Application and extension have separate conditions and documents. The certificate’s start and term also follow Article 13 rather than the request date.

Switzerland: which patent and authorisation conditions matter?

The statute requires patent protection and a Swiss medicinal authorisation, with the relevant first-authorisation basis. Record both instruments and the product they concern.

Switzerland: how are holder and earlier certificates recorded?

Retain the patent holder’s entitlement and earlier-certificate information. The statutory one-certificate rule includes qualifications for multiple pending holders; no eligibility verdict is generated.

Switzerland: which dates govern the filing branches?

Article 140f distinguishes six-month authorisation and grant branches. Preserve actual notification and grant records; do not use patent expiry as a universal filing trigger.

Switzerland: does the certificate cover every medicine use?

Protection remains within the basic patent and authorised medicinal uses. Start, term, filing fee and annuities have their own statutory provisions.

Frequently asked questions

France: which product and patent records are connected?

Match the identified product, in-force basic patent and valid authorisation. Article 3 also addresses the first authorisation and earlier certificate condition in the relevant member state.

France: why keep authorisation and patent-grant dates?

Article 7 distinguishes a six-month authorisation trigger and a later patent-grant trigger. Neither date should be substituted for the other without establishing the branch.

Switzerland: how are holder and earlier certificates recorded?

Retain the patent holder’s entitlement and earlier-certificate information. The statutory one-certificate rule includes qualifications for multiple pending holders; no eligibility verdict is generated.

Switzerland: does the certificate cover every medicine use?

Protection remains within the basic patent and authorised medicinal uses. Start, term, filing fee and annuities have their own statutory provisions.

Sources and versions

  1. ch-lbi-fr

    2025-07-01

  2. eu-ccp-consolidated-fr